Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-002254
Filing Date
2025-05-12
Accepted
2025-05-12 11:29:16
Documents
40

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10370
2 MAY 12 PRESENTATION PDF p25-1180exhibitg.pdf EX-99 1059908
3 EXHIBIT G - MAY 12 PRESENTATION p25-1180exhibitg.htm EX-99 14811
4 EXHIBIT F - PRESS RELEASE p25-1180exhibitf.htm EX-99 2603
5 GRAPHIC image_001.jpg GRAPHIC 129478
6 GRAPHIC image_002.jpg GRAPHIC 526128
7 GRAPHIC image_003.jpg GRAPHIC 339854
8 GRAPHIC image_004.jpg GRAPHIC 157945
9 GRAPHIC image_005.jpg GRAPHIC 95136
10 GRAPHIC image_006.jpg GRAPHIC 377717
11 GRAPHIC image_007.jpg GRAPHIC 346119
12 GRAPHIC image_008.jpg GRAPHIC 395546
13 GRAPHIC image_009.jpg GRAPHIC 356558
14 GRAPHIC image_010.jpg GRAPHIC 124509
15 GRAPHIC image_011.jpg GRAPHIC 283937
16 GRAPHIC image_012.jpg GRAPHIC 364797
17 GRAPHIC image_013.jpg GRAPHIC 319970
18 GRAPHIC image_014.jpg GRAPHIC 326103
19 GRAPHIC image_015.jpg GRAPHIC 316838
20 GRAPHIC image_016.jpg GRAPHIC 312248
21 GRAPHIC image_017.jpg GRAPHIC 230066
22 GRAPHIC image_018.jpg GRAPHIC 161240
23 GRAPHIC image_019.jpg GRAPHIC 208553
24 GRAPHIC image_020.jpg GRAPHIC 119448
25 GRAPHIC image_021.jpg GRAPHIC 203517
26 GRAPHIC image_022.jpg GRAPHIC 201148
27 GRAPHIC image_023.jpg GRAPHIC 297083
28 GRAPHIC image_024.jpg GRAPHIC 217316
29 GRAPHIC image_025.jpg GRAPHIC 104823
30 GRAPHIC image_026.jpg GRAPHIC 205105
31 GRAPHIC image_027.jpg GRAPHIC 149707
32 GRAPHIC image_028.jpg GRAPHIC 194853
33 GRAPHIC image_029.jpg GRAPHIC 205216
34 GRAPHIC image_030.jpg GRAPHIC 112813
35 GRAPHIC image_031.jpg GRAPHIC 605847
36 GRAPHIC image_032.jpg GRAPHIC 100289
37 GRAPHIC image_033.jpg GRAPHIC 270270
38 GRAPHIC image_034.jpg GRAPHIC 456516
39 GRAPHIC image_035.jpg GRAPHIC 91759
40 GRAPHIC image_036.jpg GRAPHIC 389257
  Complete submission text file 0000902664-25-002254.txt   14283300
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Subject) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91484 | Film No.: 25933596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Filed by) CIK: 0001940272 (see all company filings)

EIN.: 000000000 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13D/A